Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrp Advisory Group Regulatory News (FRP)

Share Price Information for Frp Advisory Group (FRP)

Share Price is delayed by 15 minutes
Get Live Data
117.00    4.00 (3.54%)
Bid:
116.00
Ask:
118.00
Spread: 2.00 (1.724%)
Market Cap: £289.10m
FRP Live PriceLast checked at - London Stock Exchange

Intraday Frp Advisory Group Share Chart

Changes in Holdings

24 Mar 2011 07:00

RNS Number : 5234D
Fairpoint Group PLC
24 March 2011
 

 

TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

 

Fairpoint Group Plc

2. Reason for the notification (yes/no)

 

An acquisition or disposal of voting rights 

 

Yes

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

No

An event changing the breakdown of voting rights

 

No

Other (please specify):___________________________________________

 

No

3. Full name of person(s) subject to the notification obligation:

Hanover I Master Fund where the shares are registered in the name of Vidacos Nominees Limited, Hanover Investment Management (Cayman) Limited and Dauphin Ventures Limited.

4. Full name of shareholder(s) (if different from 3.):

As above

 

5. Date of the transaction (and date on which the threshold is crossed or reached if different):

 

18 March 2011

6. Date on which issuer notified:

 

22 March 2011

7. Threshold(s) that is/are crossed or reached:

24%

 

 

 

8. Notified details:

 

A: Voting rights attached to shares

 

Class/type of shares 

If possible use ISIN code

Situation previous to the Triggering transaction

 Resulting situation after the triggering transaction

Number of shares

Number of voting rights

Number of shares 

Number of voting rights

Percentage of voting rights

Direct

Indirect

Direct

Indirect

Ord 1p

10,364,542

10,364,542

9,864,542

9,864,542

23.016%

 

B: Financial Instruments

 

Resulting situation after the triggering transaction

 

Type of financial instrument 

Expiration date

Exercise/ conversion period/ date

No. of voting rights that may be acquired (if the instrument is exercised / converted)

Percentage of voting rights

 

Total (A+B)

 

Number of voting rights

 

Percentage of voting rights

9,864,542

23.016%

 

 

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

Vidacos Nominees Limited controls the total voting rights; being the vehicle managed by the Prime Broker to Hanover I Master Fund LP

 

Proxy Voting:

 

10. Name of the proxy holder:

 

11. Number of voting rights proxy holder will cease to hold:

 

12. Date on which proxy holder will cease to hold voting rights:

 

 

13. Additional information:

 

14. Contact name:

 

Michael Smith

15. Contact telephone number:

 

0207 766 8400

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLPGUQGWUPGPUW
Date   Source Headline
21st May 20264:39 pmRNSHolding(s) in Company
21st May 20264:22 pmRNSPurchase of Ordinary Shares by EBT
15th May 20267:00 amRNSFull Year Trading Update
27th Apr 20267:00 amRNSShareholder Lock-Ins
20th Mar 202610:43 amRNSHolding(s) in Company
17th Mar 20261:49 pmRNSHolding(s) in Company
27th Feb 20266:15 pmRNSHolding(s) in Company
27th Feb 20266:08 pmRNSHolding(s) in Company
23rd Feb 20267:00 amRNSQ3 Dividend Declaration
13th Jan 20262:51 pmRNSChange of Auditor
9th Jan 20263:40 pmRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSGrant of Options and Director Dealing
19th Dec 20257:00 amRNSGrant of Options and Director Dealing
18th Dec 20257:00 amRNSHalf-year Report
1st Dec 20256:08 pmRNSTotal Voting Rights
21st Nov 20257:00 amRNSTrading Statement
14th Nov 20257:00 amRNSAcquisition of Arc & Co Structured Finance Limited
23rd Sep 20253:43 pmRNSResult of AGM
23rd Sep 20257:00 amRNSAGM Statement and Q1 Dividend Declaration
3rd Sep 20257:00 amRNSDirector/PDMR Shareholding
26th Aug 20255:32 pmRNSNotice of Annual General Meeting
19th Aug 202510:04 amRNSAnnual Financial Report
19th Aug 20258:45 amRNSGrant of Options and Director Dealing
23rd Jul 20257:00 amRNSFull Year Results
30th May 20257:00 amRNSTotal Voting Rights
12th May 20257:00 amRNSAcquisition of One Advisory Group
8th May 20257:00 amRNSFull Year Trading Update
1st May 20253:35 pmRNSAIM Rule 17 Update
11th Mar 20251:55 pmRNSDirector/PDMR Shareholding
17th Feb 20257:00 amRNSQ3 Trading Update and Dividend Declaration
14th Jan 20257:00 amRNSAppointment of Joint Corporate Broker
10th Jan 20255:00 pmRNSDirector/PDMR Shareholding
17th Dec 20247:00 amRNSHalf-year Report
20th Nov 20247:00 amRNSHalf Year Trading Update
31st Oct 20247:00 amRNSTotal Voting Rights
25th Oct 20247:00 amRNSHolding(s) in Company
17th Oct 20247:00 amRNSAcquisition of Globalview Advisors Limited
15th Oct 20242:42 pmRNSPDMR Dealing
30th Sep 202410:22 amRNSTotal Voting Rights
26th Sep 202410:49 amRNSResult of AGM
26th Sep 20247:00 amRNSAGM Statement and Q1 Dividend Declaration
23rd Sep 20247:00 amRNSDirector/PDMR Shareholding
4th Sep 20247:00 amRNSAcquisition of WilliamsAli Corporate Finance
23rd Aug 20247:00 amRNSNotice of AGM
16th Aug 202411:39 amRNSAnnual Report & Accounts
1st Aug 20243:35 pmRNSDirector/PDMR Shareholding
31st Jul 202410:50 amRNSTotal Voting Rights
24th Jul 20242:40 pmRNSReplacement - Full Year Results
24th Jul 20247:00 amRNSFull Year Results
19th Jul 202411:43 amRNSAcquisition of Lexington Corporate Finance

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.